Glenmede Trust’s HealthEquity HQY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $15M | Sell |
179,823
-19,061
| -10% | -$1.56M | 0.07% | 224 |
|
|
2025
Q4 | $18.2M | Buy |
+198,884
| New | +$19M | 0.09% | 197 |
|
|
2025
Q1 | $20.7M | Sell |
234,775
-5,134
| -2% | -$527K | 0.11% | 167 |
|
|
2024
Q4 | $23M | Sell |
239,909
-3,268
| -1% | -$305K | 0.12% | 159 |
|
|
2024
Q3 | $19.9M | Sell |
243,177
-4,043
| -2% | -$312K | 0.1% | 210 |
|
|
2024
Q2 | $21.3M | Buy |
247,220
+9,308
| +4% | +$752K | 0.11% | 189 |
|
|
2024
Q1 | $19.4M | Buy |
237,912
+15,037
| +7% | +$1.17M | 0.1% | 215 |
|
|
2023
Q4 | $14.8M | Sell |
222,875
-15,462
| -6% | -$1.07M | 0.08% | 271 |
|
|
2023
Q3 | $17.4M | Buy |
238,337
+1,311
| +0.6% | +$88.6K | 0.1% | 212 |
|
|
2023
Q2 | $14M | Buy |
237,026
+460
| +0.2% | +$26.7K | 0.08% | 265 |
|
|
2023
Q1 | $13.9M | Sell |
236,566
-1,356
| -0.6% | -$82.3K | 0.08% | 264 |
|
|
2022
Q4 | $14.7M | Sell |
237,922
-27,820
| -10% | -$1.87M | 0.09% | 256 |
|
|
2022
Q3 | $17.8M | Sell |
265,742
-21,566
| -8% | -$1.36M | 0.11% | 197 |
|
|
2022
Q2 | $17.6M | Sell |
287,308
-31,950
| -10% | -$2.05M | 0.1% | 224 |
|
|
2022
Q1 | $21.5M | Buy |
319,258
+232
| +0.1% | +$12.5K | 0.11% | 227 |
|
|
2021
Q4 | $14.1M | Buy |
319,026
+86,346
| +37% | +$5.03M | 0.07% | 329 |
|
|
2021
Q3 | $15.1M | Sell |
232,680
-7,347
| -3% | -$510K | 0.08% | 283 |
|
|
2021
Q2 | $19.3M | Sell |
240,027
-5,505
| -2% | -$419K | 0.1% | 237 |
|
|
2021
Q1 | $16.7M | Sell |
245,532
-64,591
| -21% | -$5.07M | 0.09% | 253 |
|
|
2020
Q4 | $21.6M | Sell |
310,123
-22,476
| -7% | -$1.4M | 0.12% | 206 |
|
|
2020
Q3 | $17.1M | Sell |
332,599
-47,721
| -13% | -$2.62M | 0.1% | 223 |
|
|
2020
Q2 | $22.3M | Sell |
380,320
-170,231
| -31% | -$9.41M | 0.14% | 183 |
|
|
2020
Q1 | $40.8M | Hold |
550,551
| – | – | 0.19% | 153 |
|
|
2019
Q4 | $40.8M | Sell |
550,551
-65,100
| -11% | -$4.06M | 0.19% | 153 |
|
|
2019
Q3 | $35.2K | Buy |
615,651
+168,730
| +38% | +$11.2M | 0.16% | 170 |
|
|
2019
Q2 | $29.2K | Sell |
446,921
-2,446
| -0.5% | -$170K | 0.13% | 227 |
|
|
2019
Q1 | $33.2K | Buy |
449,367
+43,369
| +11% | +$3.05M | 0.15% | 212 |
|
|
2018
Q4 | $24.2K | Buy |
+405,998
| New | +$32.7M | 0.12% | 252 |
|
|
2018
Q3 | – | Sell |
-227
| Closed | -$17K | – | 1617 |
|
|
2018
Q2 | $17K | Buy |
227
+129
| +132% | +$9.27K | ﹤0.01% | 1758 |
|
|
2018
Q1 | $4K | Hold |
98
| – | – | ﹤0.01% | 2457 |
|
|
2017
Q4 | $4K | Hold |
98
| – | – | ﹤0.01% | 2457 |
|
|
2017
Q3 | $4K | Hold |
98
| – | – | ﹤0.01% | 2401 |
|
|
2017
Q2 | $4K | Hold |
98
| – | – | ﹤0.01% | 2337 |
|
|
2017
Q1 | $4K | Buy |
+98
| New | +$4.34K | ﹤0.01% | 2337 |
|
Other funds holding HQY
WA
VPM
VCM
Glenmede Trust's HQY Position: Q1 2026 in Review
Glenmede Trust reduced its HealthEquity (HQY) stake by 9.6% in Q1 2026, selling an estimated $1.56M and leaving 179,823 shares worth $15M. The position accounts for 0.07% of the portfolio, ranked #224.
Glenmede Trust first reported a position in HQY in Q1 2017 and has held it in 34 quarters since. The position peaked at $40.8M in Q1 2020. 485 funds tracked by Wall St. Rank hold HQY as of Q1 2026.
- Glenmede Trust held 179,823 shares of HealthEquity worth $15M as of Q1 2026.
- Glenmede Trust sold 19,061 HealthEquity shares in Q1 2026, an estimated $1.56M.
- HealthEquity made up 0.07% of Glenmede Trust's portfolio in Q1 2026, its #224 holding.
- Glenmede Trust first reported a position in HealthEquity in Q1 2017 and has held it in 34 quarters since.
- Glenmede Trust's HealthEquity position peaked at $40.8M in Q1 2020.
- 485 funds tracked by Wall St. Rank held HealthEquity as of Q1 2026.
Based on Glenmede Trust's 13F filing for Q1 2026, filed 26 May 2026.